Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Worth 30c

<< Previous

Bullboard Posts

Next >>

Comment by allibabbaon Nov 26, 2020 3:13pm

174 Views

Post# 31982717

RE:RE:RE:RE:RE:RE:RE:Worth 30c

You make a few good points, however the 36 million in cash I smoke and mirrors. 9 million of that if receivables from hexo that will never get recovered. That leaves 2 quarters of cash at current cash burn. There is also a 30 million dollar counter suit from hexo which is not included as a liability. That alone could crush the company. The deals that they have signed have 0 dollar amounts or margins attached to them so it's all a huge risk at this point. This could succeed, but it could just as easily fail.

<< Previous

Bullboard Posts

Next >>

Global football stars and legends help launch 'EA Sports FC 25'